Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aaron J. Bouk"'
Autor:
Jianxin Shi, Xing Hua, Bin Zhu, Sarangan Ravichandran, Mingyi Wang, Cu Nguyen, Seth A Brodie, Alessandro Palleschi, Marco Alloisio, Gianluca Pariscenti, Kristine Jones, Weiyin Zhou, Aaron J Bouk, Joseph Boland, Belynda Hicks, Adam Risch, Hunter Bennett, Brian T Luke, Lei Song, Jubao Duan, Pengyuan Liu, Takashi Kohno, Qingrong Chen, Daoud Meerzaman, Crystal Marconett, Ite Laird-Offringa, Ian Mills, Neil E Caporaso, Mitchell H Gail, Angela C Pesatori, Dario Consonni, Pier Alberto Bertazzi, Stephen J Chanock, Maria Teresa Landi
Publikováno v:
PLoS Medicine, Vol 13, Iss 12, p e1002162 (2016)
BACKGROUND:Lung adenocarcinoma (LUAD) is the most common histologic subtype of lung cancer and has a high risk of distant metastasis at every disease stage. We aimed to characterize the genomic landscape of LUAD and identify mutation signatures assoc
Externí odkaz:
https://doaj.org/article/30013d5f9ba74edfbd73493a4b002027
Autor:
Frank X. Donovan, Neelam Giri, Blanche P. Alter, Aaron J. Bouk, Payal P. Khincha, Lisa Mirabello, Irina Maric, Lea Jessop, Settara C. Chandrasekharappa, Steven R. Ellis, Mia Steinberg, Seth A. Brodie, Jieqiong Dai, Sharon A. Savage, Kelvin C. de Andrade
Publikováno v:
Cold Spring Harbor Molecular Case Studies
IKZF1 encodes Ikaros, a zinc finger–containing transcription factor crucial to the development of the hematopoietic system. Germline pathogenic variants in IKZF1 have been reported in patients with acute lymphocytic leukemia and immunodeficiency sy
Autor:
K Misner, Zhao-Qi Wang, Lee E. Moore, Thorkell Andresson, Sonja I. Berndt, Stephen K. Anderson, A Esnakula, Jonathan R. Keller, Wen Yi Huang, Hong Lou, Joseph Boland, D Butcher, Sevilay Turan, Tongwu Zhang, Margaret A. Tucker, Jean-Noel Billaud, Seth A. Brodie, Meredith Yeager, S. J. Chanock, Kevin M. Brown, K M Im, W Tan, W. Isaacs, Dominic Esposito, Aaron J. Bouk, Hongchuan Li, Michael L. Nickerson, Shiva K. Das, Robert N. Hoover, Lei Sun, Michael Dean
Publikováno v:
Oncogene
Genetic alterations associated with prostate cancer (PCa) may be identified by sequencing metastatic tumor genomes to identify molecular markers at this lethal stage of disease. Previously, we characterized somatic alterations in metastatic tumors in